Search Results - "Annett, Geralyn"

Refine Results
  1. 1
  2. 2
  3. 3

    Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease by Olson, Scott D., Pollock, Kari, Kambal, Amal, Cary, Whitney, Mitchell, Gaela-Marie, Tempkin, Jeremy, Stewart, Heather, McGee, Jeannine, Bauer, Gerhard, Kim, Hyun Sook, Tempkin, Teresa, Wheelock, Vicki, Annett, Geralyn, Dunbar, Gary, Nolta, Jan A.

    Published in Molecular neurobiology (01-02-2012)
    “…There is much interest in the use of mesenchymal stem cells/marrow stromal cells (MSC) to treat neurodegenerative disorders, in particular those that are fatal…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells by Deng, Peter, Torrest, Audrey, Pollock, Kari, Dahlenburg, Heather, Annett, Geralyn, Nolta, Jan A, Fink, Kyle D

    Published in Neural regeneration research (01-05-2016)
    “…Progress to date from our group and others indicate that using genetically-engineered mesenchymal stem cells (MSC) to secrete brain-derived neurotrophic factor…”
    Get full text
    Journal Article
  6. 6

    Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells by Deng, Peter, Torrest, Audrey, Pollock, Kari, Dahlenburg, Heather, Annett, Geralyn, Nolta, Jan, Fink, Kyle

    Published in Neural regeneration research (01-01-2016)
    “…Progress to date from our group and others indicate that using genetically-engineered mesenchymal stem cells(MSC) to secrete brain-derived neurotrophic…”
    Get full text
    Journal Article
  7. 7

    MDR1 gene expression in brain of patients with medically intractable epilepsy by Tishler, D M, Weinberg, K I, Hinton, D R, Barbaro, N, Annett, G M, Raffel, C

    Published in Epilepsia (Copenhagen) (01-01-1995)
    “…Why some patients with seizures are successfully treated with antiepileptic drugs (AEDs) and others prove medically intractable is not known. Inadequate…”
    Get more information
    Journal Article
  8. 8

    Mesenchymal stem cells for the treatment of neurodegenerative disease by Joyce, Nanette, Annett, Geralyn, Wirthlin, Louisa, Olson, Scott, Bauer, Gerhard, Nolta, Jan A

    Published in Regenerative medicine (01-11-2010)
    “…Mesenchymal stem cells/marrow stromal cells (MSCs) present a promising tool for cell therapy, and are currently being tested in US FDA-approved clinical trials…”
    Get more information
    Journal Article
  9. 9

    Engineered BDNF producing cells as a potential treatment for neurologic disease by Deng, Peter, Anderson, Johnathon D, Yu, Abigail S, Annett, Geralyn, Fink, Kyle D, Nolta, Jan A

    Published in Expert opinion on biological therapy (02-08-2016)
    “…Brain-derived neurotrophic factor (BDNF) has been implicated in wide range of neurological diseases and injury. This neurotrophic factor is vital for neuronal…”
    Get more information
    Journal Article
  10. 10

    Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration by Moisseiev, Elad, Smit-McBride, Zeljka, Oltjen, Sharon, Zhang, Pengfei, Zawadzki, Robert J, Motta, Monica, Murphy, Christopher J, Cary, Whitney, Annett, Geralyn, Nolta, Jan A, Park, Susanna S

    “…Intravitreal murine lineage-negative bone marrow (BM) hematopoietic cells slow down retinal degeneration. Because human BM CD34+ hematopoietic cells are not…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors by Meyerrose, Todd, Olson, Scott, Pontow, Suzanne, Kalomoiris, Stefanos, Jung, Yunjoon, Annett, Geralyn, Bauer, Gerhard, Nolta, Jan A.

    Published in Advanced drug delivery reviews (30-09-2010)
    “…Mesenchymal stem cells (MSC) are a promising tool for cell therapy, either through direct contribution to the repair of bone, tendon and cartilage or as an…”
    Get full text
    Journal Article
  13. 13

    Contribution of human hematopoietic stem cells to liver repair by Zhou, Ping, Wirthlin, Louisa, McGee, Jeannine, Annett, Geralyn, Nolta, Jan

    Published in Seminars in immunopathology (01-09-2009)
    “…Immune-deficient mouse models of liver damage allow examination of human stem cell migration to sites of damage and subsequent contribution to repair and…”
    Get full text
    Journal Article
  14. 14

    Mesenchymal stem cells for trinucleotide repeat disorders by Annett, Geralyn, Bauer, Gerhard, Nolta, Jan A

    “…Mesenchymal stem cells/marrow stromal cells (MSCs) are ideally suited for cellular therapy due to their ease of isolation, manipulation, and strong safety…”
    Get more information
    Journal Article
  15. 15

    Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models super(MT) Open by Pollock, Kari, Dahlenburg, Heather, Nelson, Haley, Fink, Kyle D, Cary, Whitney, Hendrix, Kyle, Annett, Geralyn, Torrest, Audrey, Deng, Peter, Gutierrez, Joshua

    Published in Molecular therapy (01-05-2016)
    “…Huntington's disease (HD) is a fatal degenerative autosomal dominant neuropsychiatric disease that causes neuronal death and is characterized by progressive…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20